NCT06305559: A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque
- State
- Under way
- Phase
- Phase 3
- People
- 300 planned
- Started
- 16 May 2024
- Primary completion
- Nov 2027
- Arms
- Obicetrapib/Ezetimibe
- Results
- None posted
- 12 Mar 2024: Trial registered
- 16 May 2024: Trial started